##
|Trustees||Mrs Michaela
M Rees|Jones|||
|---|---|---|---|---|---|
|||Mr Maunce
H Craft||||
|||Mr Jonathan S M Craft||||
|||Mr Percy Beckley||||
|||Mr Laurence J F Tarlo||||
|||Mrs R L Craft||(Appointed|10November|
|||||2022)||
|Ambassadors||Mrs Cheryl Whitehead||||
|||Ms Tiffany Chawner||||
|||Ms Nicola Floyd||||
|||Mr Julian
O'Dell||||
|Patrons||Lord Alliance CBE||||
|||Harry &Carolyn
Black||||
|||Barry Boas||||
|||Roger Cadbury
Family||||
|||Harold
& Daphne Cooper Charitable||Trust||
|||Peter & Marilyn Cooper||||
|||John Emery||||
|||Alassandro
Dusi||||
|||Isabel Ettedgui||||
|||The Fallon
Family||||
|||Leonard &Ranee Feinstein||||
|||Charles & Diane Herlinger||||
|||Michael & Lottie Hunter||||
|||Bob Lefroy||||
|||Bevs Mahm||||
|||Martin
O'Connor||||
|||Sir Michael Parkinson|CBE|||
|||Sir Paul & Lady Ruddock||||
|||Ivor & Isabelle Seddon||||
|||Chns Sharp||||
|||Michaela
M Ress Jones||||
|Secretary||Mrs Joyce Fletcher (J.P.)||||
|Charity number||1143743||||
|Company|number|07767248||||
|Principal address||2 Regency Chambers||||
|||Jubilee Way||||
|||Bury||||
|||Lancashire||||
|||BL9OJW||||
|Registered|office|2 Regency Chambers||||
|||Jubilee Way||||
|||Bury||||
|||Lancashire||||
|||BL9OJW||||
##
|||||Page|
|---|---|---|---|---|
|Chairman's|statement||||
|Trustees'|report|||2-7|
|Statement|ofTrustees'||responsibilities||
|Independent
auditor's|||report|9-11|
|Statement|offinancial||actwities|12-13|
|Balance sheet||||14|
|Statement|ofcash flows|||15|
|Notes to the finanaal||statements||16-24|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|||||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|---|---|---|
|||||funds|funds|||
||||Notes|2022
f|2022f|2022f|2021f|
|Income from:||||||||
|Voluntary
income|||3|464,027|37,194|501,221|279,706|
|Investments|||4|7,005||7,005|9,628|
|Total income||||471,032|37,194|508,226|289,334|
|~Ed i||||||||
|Raising funds|||5|71,907||71,907|69,459|
|Charitable
activities|||6|339,665|138,067|477,732|1,028,978|
|Total||||411,572|138,067|549,639|1,098,437|
|Net income/(expenditure)||for the year)||||||
|Net movement|in funds|||59,460|(100,873)|(41,413)|(809,103)|
|Fund balances|at 1 October|2021||2,111,856|113,150|2,225,006|3,034,109|
|Fund balances|st 30September 2022|||2,171,316|12,277|2,183,593|2,225,006|
##
##
|Prior financial|year|||||||
|---|---|---|---|---|---|---|---|
||||||Unrestricted|Restricted|Total|
||||||funds|funds||
||||||2021|2021|2021|
|||||Notes|8|8||
|Income from:||||||||
|Voluntary
income|||||226,039|53,667|279,706|
|Investments|||||9,628||9,628|
|Total income|||||235,667|53,667|289,334|
|~Ed i||||||||
|Raising funds||||5|69,459||69,459|
|Chantable
activities||||8|1,013,959|15,019|1,028,978|
|Total|||||1,083,418|15,019|1,098,437|
|Net income/(expenditure)||for the|year/|||||
|Net movement|in funds||||(847,751)|38,648|(809,103)|
|Fund balances|at 1 October|2020|||2,959,607|74,502|3,034,109|
|Fund balances|at 30September||2021||2,111,856|113,150|2,225,006|
##
##
|||||||2022||2021||
|---|---|---|---|---|---|---|---|---|---|
||||||Notes|5||6||
|Current assets||||||||||
|Debtors||||||391||381||
|Cash at bank and||in|hand|||2,239,418||2,302,991||
|||||||2,239,809||2,303,372||
|Creditors:|amounts||falling due within|||||||
|one year|||||12|(56,216)||(78,366)||
|Net current|assets||||||2,183,593||2,225,006|
|Funds ofthe charity||||||||||
|Restricted|funds||||13||12,277||113,150|
|Unrestncted|funds.|||||||||
|General unrestncted||||funds|||658,197||641,903|
|Designated||funds|||14||1,513,119||1,469,453|
||||||||2,183,593||2,225,006|
##
##
||||||2022|||2021||
|---|---|---|---|---|---|---|---|---|---|
||||Notes|6|||6|||
|Cash flows from operating||activities||||||||
|Cash absorbed
by operations|||17|||(70,578)|||(839,998)|
|Investing|activities|||||||||
|Investment|income received|||7,005|||9,628|||
|Net cash
activities|generated
from|investing||||7,005|||9,628|
|Net cash|used
in financing|activities||||||||
|Net decrease
in cash and||cash equivalents||||(63,573)|||(830,370)|
|Cash and|cash equivalents|at beginning|ofyear|||2,302,991|||3,133,361|
|Cash and|cash equivalents|at end of|year|||2,239,418|||2,302,991|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||||||N0
N|CIC|Ch
Yl
0|I
ID
CD
ID|CD
0
Dl|
|---|---|---|---|---|---|---|---|---|---|---|---|
||||||||||||N|
||||||'D
Ot
II|IO
CO|N0|Ol|IA
IA
N||CD
5|
||||||||||IA||IA|
||||||IO|||||||
||||||Ol|||||||
||||||'a8|IO
CO|N0
N|Ctt|CO
CD|IA
IA
I|CO
0
CD
N|
||||||IO|||||||
||||||D|||||||
||||||80||N
N0
N|CIC|N
N
CD|0
0
0
IAN|N
0|
||||||||||||IA|
||||||'U
Ot
D|Ol
CO0
I|N
N0
N|Cll|C
CO|0
0
0
IAN|CO
CA|
||||||IO|||||||
||||||IO|||||||
||||||CO3
I|Ol
0|N
CV0
N|III|0
CD||N
0I
CD|
||||||IO|||||||
|0|||||IO0|||||||
|LUI-||||||||||||
|z0I-
z
cL'aZ
po
0
V)
ized|||OlO
Nl|||||||||
|Ill||||||||||||
|||LU||||||||||
|IXI|||Cl|||||||||
|LUI-
—~ cC
~ LUrn
z U
Ueo
Z &
I-oz
z
LL~g
~ Ng LL|||I~
Q.
O
0
CI||||||CO|Q||
|&|g UJ
~z|||L|||||tO|Qt
Dt||
|4~a
iOrn
LU I- 8-
ZUO
I- cL'z|||4l
0|0|||||IO
IO0
0
Cl|Vl
tO
C
tt||
##
##
|4|Investments|Investments||||||
|---|---|---|---|---|---|---|---|
|||||||Unrestricted|Unrestricted|
|||||||funds|funds|
|||||||2022|2021|
|||||||f||
||Interest receivable|||||7,005|9,628|
|5|Raising|funds||||||
|||||||Unrestricted|Unrestricted|
|||||||funds|funds|
|||||||2022f|2021
5|
||Costs of|generating||voluntary|income|||
||Travelhng|and subsistence||||112||
||Printing,|stationery||and postage||1,091|1,130|
||Fundraising
expenses|||||463||
||Other expenses|||||298|177|
||Advertising|||||475|445|
||Other fundraising||costs|||615|266|
||Staff costs|||||67,958|66,594|
||Insurance|||||895|847|
||Costs of|generating||voluntary|income|71,907|69,459|
##
##
|||Unrestricted|Restricted|TotalUnrestricted|TotalUnrestricted|Restricted|Total|
|---|---|---|---|---|---|---|---|
|||2022|2022
5|2022
6|2021
6|2021
5|2021f|
|LMTK3 drug development||91,781||91,781|308,789||308,789|
|Cancer stem cells research|||100,873|100,873||||
|PhD and other student||||||||
|bursaries||64,622||64,622|99,393||99,393|
|Ovarian cancer research||12,627||12,627|23,094||23,094|
|Pancreatic cancer research||25,238||25,238|14,808||14,808|
|Genetic switches||66,530||66,530|134,508||134,508|
|Breast cancer research||73,850|37,194|111,044|428,075|15,019|443,094|
|Other research project|||||232||232|
|||334,648|138,067|472,715|1,008,899|15,019|1,023,918|
|Share ofgovernance|costs|||||||
|(see note 7)||5,017||5,017|5,060||5,060|
|||339,665|138,067|477,732|1,013,959|15,019|1,028,978|
|Analysis
by fund||||||||
|Unrestricted
funds||339,665||339,665|1,013,959||1,013,959|
|Restricted
funds|||138,067|138,067|-|15,019|15,019|
|||339.665|138,067|477,732|1,013,959|15,019|1,028,978|
##
##
##
|||||||||||||2022|2021|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||||||||||Number||Number|
||Management|||||||||||||
||Employment|costs||||||||||2022
f|2021
f|
||Wages and salaries||||||||||64,250||62,720|
||Social secunty|costs||||||||||2,425|2,591|
||Other pension|costs||||||||||1,283|1,283|
||||||||||||67,958||66,594|
||No employees|had annual||remuneration|||off60,000or more.|||||||
||Many of the research||proiects||involve the use of PhD students.|||||Action Against Cancer||is currently|funding
a|
||number
of PhD studentships|||and||fellowships
at Imperial||College||to support the research||work.||
|10|Taxation|||||||||||||
||The charity
is|exempt|from|tax|on|income|and gains falling||within|section 505 ofthe|Taxes Act 1988or section|||
||252 ofthe Taxation of||Chargeable|||Gains|Act 1992to the|extent that these are applied|||to|its charitable objects.||
|11|Debtors|||||||||||||
|||||||||||||2022|2021|
||Amounts
falling due||within one|||year:|||||||f|
||Prepayments|and accrued||income||||||||391|381|
##
##
|Creditors:|a|m|oun|ts|falling|due|within o|ne year||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||||||2022|2021|
|||||||||||||E|E|
|Trade creditors||||||||||||54,422|76,808|
|Other creditors||||||||||||1,794|1,558|
|||||||||||||56,216|78,366|
|Restricted|funds|||||||||||||
|The income||funds||of the charity|||include|restricted|funds|comprising|the following|unexpended|balances
of|
|donations|and||grants||held on|trust|for specific purposes:|||||||
|||||||Movement||in funds|||Movement|in funds||
|||||Balance at|||Income|Expenditure||Balance at|Income|Expenditure|Balance at|
||||1 October 2020||||||1 October 2021||||30 September|
||||||||||||||2022|
||||||||||||E|E|E|
|Cancer stem||||||||||||||
|cells research|||||59,483||53,667|||113,150||(100,873)|12,277|
|Breast cancer||||||||||||||
|research|||||15,019|||(15,019)|||37,194|(37,194)||
||||||74,502||53,667|(15,019)||113,150|37,194|(138,067)|12,277|
##
##
##
##
##
|15|Analysis|ofnet assets|between funds||||||
|---|---|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total|Unrestricted|Restricted|Total|
||||funds|funds||funds|funds||
||||2022|2022|2022|2021|2021|2021|
||||8|6|6|F|6||
||Fund balances at 30||||||||
||September 2022 are||||||||
||represented
by:||||||||
||Current|assets/(liabilities)|2,171,316|12,277|2,183,593|2,111,856|113,150|2,225,006|
||||2,171,316|12,277|2,183,593|2,111,856|113,150|2,225,006|
##
##
|||||||||
|---|---|---|---|---|---|---|---|
|Cash generated
from||operations||||2022|2021|
|||||||6||
|Deficit for the year||||||(41,413)|(809,103)|
|Adjustments|for:|||||||
|Investment|income recognised||in statement|of finanaal|activities|(7,005)|(9,628)|
|Movements|in working|capital.||||||
|(Increase)|in debtors|||||(10)||
|(Decrease)|in creditors|||||(22,150)|(21,267)|
|Cash absorbed
by operations||||||(70,578)|(839,998)|
##